Recurrent varicella following SARS-CoV-2 vaccination with BNT162b2

Int J Dermatol. 2021 Sep;60(9):1148-1149. doi: 10.1111/ijd.15660. Epub 2021 May 17.

Authors

Krassimira Nanova¹, Abraham Zlotogorski², Yuval Ramot²

Affiliations

¹ Clalit Health Services, Jerusalem, Israel.
² Department of Dermatology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

No abstract available

Publication types

Letter

MeSH terms

BNT162 Vaccine
COVID-19 Vaccines
COVID-19*
Chickenpox*
Humans
SARS-CoV-2
Vaccination

Substances

COVID-19 Vaccines
BNT162 Vaccine